Daniel L. Goodwin’s Medifast MED Stock Holding History

Daniel L. Goodwin’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-25,000	Closed	-$2.74M	–	95
2019 Q4	$2.74M	Buy	+25,000	New	+$2.42M	1.19%	10

Other funds holding MED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $423M AUM 49.14% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Daniel L. Goodwin's MED Position: Q1 2020 in Review

Daniel L. Goodwin sold out of Medifast (MED) in Q1 2020, closing a stake of 25,000 shares — an estimated $2.74M sold.

Daniel L. Goodwin first reported a position in MED in Q4 2019 and held it in 1 quarter. The position peaked at $2.74M in Q4 2019. 201 funds tracked by Wall St. Rank hold MED as of Q1 2020.

Daniel L. Goodwin reported no remaining Medifast position as of Q1 2020 after selling out during the quarter.
Daniel L. Goodwin sold 25,000 Medifast shares in Q1 2020, an estimated $2.74M.
Daniel L. Goodwin first reported a position in Medifast in Q4 2019 and held it in 1 quarter.
Daniel L. Goodwin's Medifast position peaked at $2.74M in Q4 2019.
201 funds tracked by Wall St. Rank held Medifast as of Q1 2020.

Based on Daniel L. Goodwin's 13F filing for Q1 2020, filed 17 Apr 2020.